Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Anhui Anke Biotech Nearly Triples in ChiNext’s First Day

publication date: Oct 30, 2009

The Shenzhen Growth Market, now called ChiNext, opened for its first day of business today, and Anhui Anke Biotechnology (Group) Co Ltd was the star performer, nearly tripling in value in its first day of open market trading. 28 medium and small-sized China companies listed on the exchange and each of the 28 did well in the first day. In fact, at one point, each was up at least 45%. However, Anhui Anke was the standout performer. More details...

Stock Symbol: (300009)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital